<DOC>
	<DOCNO>NCT03065036</DOCNO>
	<brief_summary>The purpose study evaluate ocular hypotensive effect Hydrus Aqueous Implant ( Standard Low-Profile ) , determine change IOP baseline ( preoperative ) change number glaucoma medication baseline .</brief_summary>
	<brief_title>Safety Efficacy Study Hydrus Aqueous Implant Subjects With POAG</brief_title>
	<detailed_description>This prospective , multi-center study examine subject document mild advanced primary open angle glaucoma ( POAG ) , may may cataract require removal placement intraocular lens . Study subject group severity disease ( either mild/moderate advanced ) . If inclusion exclusion criterion meet subject four group implant Hydrus Aqueous Implant . Subjects cataract present undergo standard cataract removal IOL implantation concurrent implantation Hydrus . Postoperatively , subject undergo complete ophthalmic evaluation regularly schedule interval .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Elevated intraocular pressure ( IOP ) Diagnosis mild advance openangle glaucoma Shaffer Grade III Mental capacity cooperate undergo operative postoperative examination 18 year age old Provide write informed consent Willing able return schedule followup examination 24months Closedangle narrowangle form glaucoma Secondary glaucoma Congenital developmental glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Primary Open Angle Glaucoma</keyword>
	<keyword>POAG</keyword>
</DOC>